參考文獻/References:
[1] 方玲,李旭生,樊曉海,等.強直性脊柱炎活動期與非活動期IL-6、TNF-α及CRP檢測的意義[J].中國骨腫瘤骨病,2010,9(6):536-538.
[2] 林東方,趙巖.強直性脊柱炎患者使用生物制劑宜治療早不宜晚[J].新醫(yī)學,2011,42(3):201-202.
[3] 黃烽,朱劍,張江林,等.強直性脊柱炎[M].北京:人民衛(wèi)生出版社,2011:28.
[4] 黃烽.強直性脊柱炎治療的新探索[J].中華風濕病學雜志,2003,7(7):385-387.
[5] 單振興,韓金祥,崔亞洲,等.強直性脊柱炎患者血清中DKK-1的表達及其意義[J].醫(yī)學檢驗與臨床,2011,22(1):1-7.
[6] Karkucak M,Capkin E,Alver,A,et,al.The effect of anti-TNF agent on oxidation stahus in patients with ankylosing spondylitis [J].Clin Rheumatol,2010,29(3):303-307.
相似文獻/References:
[1]戴霞華,李寅潔.指導性功能鍛煉在兒童強直性脊柱炎護理中的應用[J].中醫(yī)正骨,2015,27(10):78.
[2]張夢雨,鮑鐵周,田江波.督脈隔姜灸聯(lián)合柳氮磺吡啶腸溶片口服及
功能鍛煉治療強直性脊柱炎[J].中醫(yī)正骨,2015,27(09):44.
[3]閻曉霞,任之強,仝允輝,等.布魯氏菌性脊柱炎3例[J].中醫(yī)正骨,2015,27(06):64.
[4]張董喆,孔超,張建福.針刺夾脊穴結(jié)合督灸治療強直性脊柱炎[J].中醫(yī)正骨,2014,26(07):58.
[5]吳建國.強直性脊柱炎并發(fā)脊柱骨折的影像學表現(xiàn)[J].中醫(yī)正骨,2013,25(06):31.
[6]謝國華,薛峰,楊建平,等.強直性脊柱炎脊柱應力性骨折的診斷[J].中醫(yī)正骨,2012,24(12):72.
[7]張萬義,張永紅,王笑青.雙醋瑞因膠囊聯(lián)合柳氮磺胺吡啶腸溶片與右旋布洛芬膠囊治療強直性脊柱炎[J].中醫(yī)正骨,2012,24(06):26.
ZHANG Wan-yi*,ZHANG Yong-hong,WANG Xiao-qing.*.Study on the curative effects of diacerein capsules combined with sulfasalazine enteric-coated tablets and dextral ibuprofen capsules in the treatment of ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(11):26.
[8]黃建華,黃建武,陳金春,等.早期強直性脊柱炎血管內(nèi)皮生長因子、C反應蛋白
表達水平的臨床研究[J].中醫(yī)正骨,2012,24(02):9.
HUANG Jian-hua*,HUANG Jian-wu,CHEN Jin-chun,et al.Clinical research on the expression of VEGF、CRP in early ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(11):9.
[9]王笑青,張永紅,王玉麗,等.常規(guī)藥物口服配合中藥離子導入治療強直性脊柱炎肌腱附著點炎[J].中醫(yī)正骨,2011,23(10):18.
WANG Xiao-qing*,ZHANG Yong-hong,WANG Yu-li,et al.A study on the curative effects of oral conventional drugs combined with traditional Chinese medicine iontophoresis on ankylosing spondylitis tendon enthesitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(11):18.
[10]劉紅軍.單節(jié)段楔形截骨結(jié)合椎弓根A-F系統(tǒng)內(nèi)固定
治療強直性脊柱炎脊柱后凸畸形[J].中醫(yī)正骨,2011,23(09):65.